Opening opportunity to anyone, anywhere

Join the leading biotech startup accelerator in Europe! By connecting entrepreneurs with corporations and organizations around the globe, we drive innovation and solve the world’s biggest problems.

Let’s chat

Abundance Gate addresses crucial gaps in the European innovation ecosystem

Abundance Gate is an interdisciplinary lab facility & international innovation hub designed to address crucial gaps in the European innovation ecosystem by offering 18,000m2 state-of-the-art lab space, a deep tech VC fund, and advisory services aligning scientists, academics, experts, corporates and investors to realize biotech startups’ highest potential in tackling some of the world’s most challenging problems. We focus on life sciences, food sciences and cross-sections such as AI, robotics, sensor technologies and quantum computing. We bridge the gap between startup company and corporate company, bringing together the best of both worlds. We accelerate commercially and socially valuable innovations that make a difference - for our society, our planet and our economy.

Mission

Building an inclusive, resilient and dynamic ecosystem for co-creation, scalable application and real impact.

We believe that real innovation is based on real science. This is why we focus on creating value along the entire lab-to-market value chain, across the scientific, technical, legal, commercial, financial, regulatory and strategic fields.

Vision

Creating an abundant future through connecting science and entrepreneurship and solving humanities most pressing challenges.

We build commercially and socially valuable startups that make a difference - for our society, our planet and our economy.
10+
Biotech Startups
1000 m2
in operation
10.000 m2
under construction

Sectors

Biotech

Cross-Sections

Cross-Section

Biotech

Biotech

Biotech

The new building blocks of biology now stretch far beyond their origin. From AI to scaling and automation, these platforms are expanding the limits of what biology can do, from the lab bench to the world.

Cross-Section

Biotech

Cross-Sections

Biotech

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Food Sciences

Food sciences happen at the intersection of biology, chemistry and other technologies that analyze and study the core elements of food. They focus on novel approaches to increase nutritional content of the food we eat, develop new sources of food and pioneer novel solutions to make our food sources healthier and safer.

Cross-Section

Biotech

Cross-Sections

Food Sciences

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Life Sciences

Life sciences is the study of living organisms and life processes. As we enter a new era of medicine, novel insights and techniques across biochemistry, biophysics, and structural biology are expanding the horizon of what we can prevent, diagnose, and treat. Engineered cells, gene therapy, smart, personalized and targeted medicine, are all among the next generation of analytics and therapeutics that will define how we will live.

Cross-Section

Biotech

Cross-Sections

Life Sciences

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Agricultural Sciences

Agricultural sciences combine novel technologies across crop science, data analytics, robotics, automation, and beyond. Faced with an ever-growing demand for agricultural output on our already strained planet, these technologies help engineer novel, more innovative, healthier, and greener means of production while they also increase crop management efficiency and offer techniques for large-scale deployment.

Cross-Section

Biotech

Cross-Sections

Agricultural Sciences

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Artificial Intelligence

Artificial Intelligence (AI) constitutes a field of technologies, such as machine learning and deep learning, that use computational analysis of large datasets of all sorts. The scale of complexity enhancement, it can develop across a wide range of scientific fields, makes AI a truly revolutionizing cross-sectional technology. By performing tasks that usually require human intelligence, such as visual, speech or pattern recognition, process optimization or other forms of decision making, and using those for simulation or predictive capacity, AI holds the power to fundamentally improve the process of scientific innovation.

Cross-Section

Biotech

Cross-Sections

Artificial Intelligence

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Cognitive Algorithms

Cognitive algorithms are a form of AI technology that can perform any form of learning and reasoning, be it in supervised or unsupervised manner. Its transformative power lies in its ability to replicate, simulate, complement, and enhance human behavior across a wide range of application fields.

Cross-Section

Biotech

Cross-Sections

Cognitive Algorithms

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Robotic Process Automation

Robotic Process Automation (RPA) is a software technology running on physical or virtual machines that mimics and automates specific processes and actions by managing software derived robots that ultimately perform the tasks. These (metaphorical) software robots are so transformative since they can not only emulate how human beings interact with software in general, but also perform high-volume and repetitive tasks with applications in a wide array of industries.

Cross-Section

Biotech

Cross-Sections

Robotic Process Automation

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Sensor Technology

Sensor technology is a key cross-section technology as it is by definition the connecting “door” between the physical and the virtual world. The deployment of sensors is key to acquiring and collecting data by transforming information of physical, chemical or biological nature and forms the basis on which computational systems and other data processing technologies can be applied.

Cross-Section

Biotech

Cross-Sections

Sensor Technology

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Bioengineering

Bioengineering is a crucial cross-section technology as it applies the tools of engineering, mathematics and physical sciences with the principles of biology, medicine and life sciences. By applying design, analysis and processes to biological systems and biomedical technologies novel fields of application emerge.

Cross-Section

Biotech

Cross-Sections

Bioengineering

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Cross-Section

Biotech

Biotech

Nanotechnology

Nanotechnology is defined as the technology field dealing with structures, devices and systems that have dimensions in the order of 100 nanometres, or 100 millionth of a millimetre, or less. By designing, producing or manipulating atoms and molecules at the nanoscale, novel technological solutions and revolutionizing applications become possible across a multitude of scientific fields.

Cross-Section

Biotech

Cross-Sections

Nanotechnology

Horizontal complementary technologies in the range from "cognitive computing" to "nanotech" that support the development of the vertical biotechnology sectors.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
We bridge the gap between founders and corporate partners 
We bridge the gap between founders and corporate partners 

“Exponential tech creates abundance, let’s take the opportunities and advantages.“
At Abundance Gate we give you the power to accelerate your technology developing your business. We provide professional services and competences to foster late seed and series stage start ups companies. Our ecosystem is a compelling place to work, a compelling place to achieve.

Thomas Holzhuber
CEO | Co- Founder
Thomas Holzhuber

“Exponential tech creates abundance, let's take the opportunities and advantages.” At Abundance Gate we give you the power to accelerate your technology developing your business. We provide professional services and competences to foster late seed and series stage startup companies. Our ecosystem is a compelling place to work, a compelling place to achieve.

Thomas Holzhuber
CEO & Co- Founder
Darryl McConnel

"At Boehringer Ingelheim, we are always looking to support new technologies and creative approaches to develop more effective treatments for disease. We welcome Abundance Gate and their Lab to Market infrastructure initiative. As an innovation-driven company, we are looking forward to the enrichment for biotech startups in Vienna. As a corporate player in life science we value the dynamic atmosphere of Abundance Gate, which startup companies need to succeed."

Darryl McConnel
Senior Vice President, Research Site Head Austria bei Boehringer Ingelheim RCV GmbH & Co KG
Timur Topalgoekceli

"Biotech start-ups benefit society by solving unsolved scientific and medical problems, but more needs to be done to bring their technologies to market faster. This requires dedicated mentors, selective training, a community, network connections and access to sources of capital. This is where Abundance Gate comes in: Programmes that provide intensive mentoring, selective training, a community of startup founders and exposure to companies and investors." 

Timur Topalgoekceli
Startup Lead | Co-Founder
Arne Materna

“Ares Genetics, an OpGen Group Company, is developing next-generation services and solutions for the genomic diagnosis and surveillance of infectious diseases and the AI-assisted prediction of pathogen response to antibiotic therapy. We chose Abundance Gate for our new home base in Vienna due to state of the art lab space and facility services that are tailored to our needs. The Abundance Gate incubator can offer the dynamic atmosphere needed to take your business idea to the next level.”

Arne Materna
CEO, Ares Genetics
Taraneh Abdelrahimsei

"Community building & stakeholder engagement is one of the most important areas in leading successful businesses. Knowledge transfer, understanding market needs, driving innovation as well as identifying risks and opportunities evolve from regular and ongoing discourse with the community.“

Taraneh Abdelrahimsei
Community Relations
Florian Rüker

"In my 30 years as a professor of molecular biology at BOKU Vienna, I have accompanied many founders in their companies. At some point they reach the point where commercial development and fundamental funding is necessary to succeed. Abundance Gate provides excellent solutions for such requirements."

Florian Rüker
Professor (retired) of Molecular Biology and Protein Engineering | Founder of F-Star Therapeutics Inc.
Berthold Baurek-Karlic

"Venionaire is an independent Venture Capital specialist and trusted partner of many investors- from Family Offices to large corporates. We are entrepreneurial partners and provide startups a global platform and network to scale. Abundance Gate is a highly valued partner of ours in acceleration and business development. Abundance Gate provides expertise and passion to navigate start-ups through early technology challenges, first product market fit and achieve commercial readiness for scale. "

Berthold Baurek-Karlic
CEO of Venionaire Capital
Irene Fialka

"INiTS is the Vienna‘s high-tech incubator. We have supported researchers to launch and grow innovative research/technology-based startups since 2002. Abundance Gate is a great enrichment to the LifeSciences scene in Austria, offering startups urgently needed lab space and network to take them to the next level during and after their time with INiTS. We really appreciate this private initiative, which helps to keep companies with their technologies and employees in Vienna and contribute to the competitiveness of our LifeSciences industry."

Irene Fialka
CEO Managing Director Health Hub Vienna
Niki Futter

"As a series and experienced business angel I value the approach how Abundance Gate enters the market of the biotech and bioengineering startup ecosystem. The professional acceleration program to guide and lead science technology to sound business is an outstanding success driver. Abundance Gate opens a great pipeline to invest in the most promising biotech startups."

Niki Futter
Investor, Series Business Angel, President AAIA

Values

Living values is essential for creating a successful and ethical business.
More news

Discover more

Free white paper download

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc vulputate libero et velit interdum, ac aliquet odio mattis. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos.

Download now

Willing to accelerate? Get your boost!

Contact us with any questions or inquiries you may have! We’d love to chat.

Have someone specific in mind?

Stay connected!

Looking to learn more about acceleration, collaboration or investment opportunities within the Abundance Gate ecosystem?

Sign up for our newsletter to stay in touch!